Clinical manifestations in MODY10 patients are variable as mildly affected patients can be controlled with diet and exercise, or in more severe cases as this patient, the clinical course is similar to that of patients with type 1 diabetes in the progressive beta cell deficiency requiring insulin therapy for life [18,19]. The gene discussed is INS; the disease is type 1 diabetes mellitus.